Tables S1 and S2 from KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells

Authors:
  • CLCheryl A. London
    Cheryl A. London
  • HGHeather L. Gardner
    Heather L. Gardner
  • SRSarah Rippy
    Sarah Rippy
  • GPGerald Post
    Gerald Post
  • KPKrista La Perle
    Krista La Perle
  • LCLinda Crew
    Linda Crew
  • LLLori Lopresti-Morrow
    Lori Lopresti-Morrow
  • AGAndrew J. Garton
    Andrew J. Garton
  • GMGerald McMahon
    Gerald McMahon
  • TLTheresa M. LaVallee
    Theresa M. LaVallee
  • RGRichard Gedrich
    Richard Gedrich

Abstract
Table S1: KTN0158 Dosing Cohorts Table S2: Summary of Anti-KTN0158 Antibody Titers in Dogs with Mast Cell Tumors Following KTN0158 Treatment